InChI=1S/C49H85O13P/c1- 3- 5- 7- 9- 11- 13- 15- 17- 19- 20- 21- 22- 24- 25- 27- 29- 31- 33- 35- 37- 42(50) 59- 39- 41(40- 60- 63(57,58) 62- 49- 47(55) 45(53) 44(52) 46(54) 48(49) 56) 61- 43(51) 38- 36- 34- 32- 30- 28- 26- 23- 18- 16- 14- 12- 10- 8- 6- 4- 2/h11- 14,17- 19,21- 23,41,44- 49,52- 56H,3- 10,15- 16,20,24- 40H2,1- 2H3,(H,57,58) /b13- 11- ,14- 12- ,19- 17- ,22- 21- ,23- 18- /t41- ,44- ,45- ,46+,47- ,48- ,49- /m1/s1 |
QEXGQJPSYREGSR-STLQCANHSA-N |
C(\CCCCCCCC(O[C@@H] (COP(O[C@H] 1[C@@H] ([C@H] ([C@@H] ([C@H] ([C@H] 1O) O) O) O) O) (=O) O) COC(=O) CCCCCCCC/C=C\C/C=C\C/C=C\CCCCC) =O) =C\C/C=C\CCCCC |
|
human metabolite
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
|
|
View more via ChEBI Ontology
Outgoing
|
1- [(10Z,13Z,16Z)- docosatrienoyl]- 2- linoleoyl- sn- glycero- 3- phospho- 1D- myo- inositol
(CHEBI:89249)
has functional parent
(10Z,13Z,16Z)-docosatrienoic acid
(CHEBI:83747)
1- [(10Z,13Z,16Z)- docosatrienoyl]- 2- linoleoyl- sn- glycero- 3- phospho- 1D- myo- inositol
(CHEBI:89249)
has functional parent
linoleic acid
(CHEBI:17351)
1- [(10Z,13Z,16Z)- docosatrienoyl]- 2- linoleoyl- sn- glycero- 3- phospho- 1D- myo- inositol
(CHEBI:89249)
has role
human metabolite
(CHEBI:77746)
1- [(10Z,13Z,16Z)- docosatrienoyl]- 2- linoleoyl- sn- glycero- 3- phospho- 1D- myo- inositol
(CHEBI:89249)
is a
1-phosphatidyl-1D-myo-inositol
(CHEBI:16749)
|
|
(2R)- 3- [(hydroxy{[(1S,2R,3R,4S,5S,6R)- 2,3,4,5,6- pentahydroxycyclohexyl]oxy}phosphoryl)oxy]- 2- {[(9Z,12Z)- octadeca- 9,12- dienoyl]oxy}propyl (10Z,13Z,16Z)- docosa- 10,13,16- trienoate
|
1-(10Z,13Z,16Z-Docosatrienoyl)-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phospho-(1'-myo-inositol)
|
HMDB
|
1-(10Z,13Z,16Z-Docosatrienoyl)-2-linoleoyl-sn-glycero-3-phosphoinositol
|
HMDB
|
1- [(10Z,13Z,16Z)- docosatrienoyl]- 2- [(9Z,12Z)- octadecadienoyl]- sn- glycero- 3- phospho- 1D- myo- inositol
|
ChEBI
|
[(2R)- 3- [(10Z,13Z,16Z)- docosa- 10,13,16- trienoyloxy]- 2- [(9Z,12Z)- octadeca- 9,12- dienoyloxy]propoxy]({[(1s,3R)- 2,3,4,5,6- pentahydroxycyclohexyl]oxy})phosphinic acid
|
HMDB
|
Phosphatidylinositol(22:3/18:2)
|
HMDB
|
Phosphatidylinositol(22:3n6/18:2n6)
|
HMDB
|
Phosphatidylinositol(22:3w6/18:2w6)
|
HMDB
|
Phosphatidylinositol(40:5)
|
HMDB
|
PI(22:3(10Z,13Z,16Z)/18:2(9Z,12Z))
|
HMDB
|
PI(22:3/18:2)
|
HMDB
|
PI(22:3n6/18:2n6)
|
HMDB
|
PI(22:3w6/18:2w6)
|
HMDB
|
PI(40:5)
|
HMDB
|
PIno(22:3/18:2)
|
HMDB
|
PIno(22:3n6/18:2n6)
|
HMDB
|
PIno(22:3w6/18:2w6)
|
HMDB
|
PIno(40:5)
|
HMDB
|
20671299
|
PubMed citation
|
Europe PMC
|
|